US2018368705A1PendingUtilityA1
Systems and methods for revascularization assessment
Est. expiryAug 14, 2033(~7.1 yrs left)· nominal 20-yr term from priority
A61B 5/6829A61B 5/6831A61B 5/0261A61B 5/02007A61B 5/0075A61B 5/726A61B 5/7246G16H 50/20A61B 5/6832A61B 5/0265A61B 5/7282A61B 5/7257G06F 19/00
57
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed herein are systems and methods for revascularization assessment. The methods can in some cases include one or more of the steps of measuring blood perfusion as a function of time to obtain time series data, mathematically transforming the time series data into a power spectrum, calculating at least one parameter of the power spectrum within a specific frequency range, and using the at least one calculated parameter as a discriminator for the first population and the second population.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A computer-implemented method for discriminating between at least a first population and a second population, the method comprising:
measuring blood perfusion as a function of time to obtain time series data; mathematically transforming the time series data into a power spectrum; calculating at least one parameter of the power spectrum within a specific frequency range; and using the at least one calculated parameter as a discriminator for the first population and the second population.
2 . The method of claim 1 , wherein at least the first population and the second population comprise two patient populations.
3 . The method of claim 1 , wherein the first population comprises a healthy control group and the second population comprises an ischemic population.
4 . The method of claim 1 , wherein measuring blood perfusion as a function of time comprises using an optical measurement method.
5 . The method of claim 4 , wherein the optical method is diffuse correlation spectroscopy.
6 . The method of claim 4 , wherein the optical method is diffuse speckle contrast analysis.
7 . The method of claim 4 , wherein the optical method is diffuse optical tomography.
8 . The method of claim 4 , wherein the optical method is near-infrared spectroscopy.
9 . The method of claim 4 , wherein the optical method is laser Doppler flowmetry.
10 . The method of claim 1 , wherein measuring blood perfusion as a function of time comprises using a non-optical measurement method.
11 . The method of claim 10 , wherein the non-optical measurement method is selected from the group consisting of an electrical measurement method and a magnetic measurement method.
12 . The method of claim 1 , wherein measuring blood perfusion as a function of time comprises using an electrical or magnetic measurement method.
13 . The method of claim 1 , wherein mathematically transforming the time series data into a power spectrum comprises using a Fourier transform.
14 . The method of claim 1 , wherein mathematically transforming the time series data into a power spectrum comprises using a fast Fourier Transform.
15 . The method of claim 1 , wherein mathematically transforming the time series data into a power spectrum comprises using a wavelet transform.
16 . The method of claim 1 , wherein the specific frequency range is between about 0.001 Hz and about 1000 Hz.
17 . The method of claim 1 , wherein the specific frequency range is between about 0.001 Hz and about 0.1 Hz.
18 . The method of claim 1 , wherein the specific frequency range is between about 0.045 Hz and about 0.1 Hz.
19 . The method of claim 1 , wherein the frequency range of interest is between 0.001 Hz and 0.045 Hz.
20 . The method of claim 1 , wherein the at least one parameter is the area under the curve of the power spectrum within the specific frequency range.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.